Farther Finance Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35
| Closed | -$18 | – | 4494 |
|
|
2024
Q4 | $18 | Sell |
35
-29
| -45% | -$15 | ﹤0.01% | 3938 |
|
|
2024
Q3 | $239 | Hold |
64
| – | – | ﹤0.01% | 3606 |
|
|
2024
Q2 | $354 | Sell |
64
-24
| -27% | -$133 | ﹤0.01% | 3353 |
|
|
2024
Q1 | $420 | Sell |
88
-4
| -4% | -$19 | ﹤0.01% | 3068 |
|
|
2023
Q4 | $481 | Buy |
+92
| New | +$481 | ﹤0.01% | 2988 |
|